News

Latest

A nationally-recognized leader in hospital/physician relations and clinical integration, Nicholas Wolter, M.D., former CEO of Billings Clinic in Billings, Mont., died Sept. 7.
The AHA today voiced support for a Federal Communications Commission proposal to create a $100 million pilot program to support telehealth for low-income Americans.
Hospitals participating in the first year of Medicare’s Comprehensive Care for Joint Replacement Model reduced payments for lower extremity joint replacement episodes by an average 3.3 percent more than hospitals that did not participate in the model.
The Food and Drug Administration Friday approved a new dosage option for buprenorphine and naloxone sublingual film, applied under the tongue as a maintenance treatment for opioid dependence.
Employment at the nation's hospitals rose by 0.16% in August to a seasonally adjusted 5,189,300 people, the Bureau of Labor Statistics reported Friday.
by Nancy Agee
The AHA is opening a new chapter in advancing health in America.
The Senate is expected to vote next week on the Opioid Crisis Response Act of 2018, a substitute amendment to the House-passed opioid package (H.R. 6).
The AHA appreciates the steps the Centers for Medicare & Medicaid Services is taking to streamline the Quality Payment Program and reduce burden for clinicians, but “is very concerned about the collapse of payment rates for evaluation and management visit codes.”
The House Energy and Commerce Health Subcommittee today approved legislation that would prohibit Medicare and private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance.
The Food and Drug Administration today released for public comment a revised draft memorandum of understanding for states regarding interstate distribution of “inordinate amounts” of compounded drugs by licensed pharmacists or physicians.